Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$121K Sell
535
-155
-22% -$37.6K 0.03% 154
2022
Q2
$168K Buy
690
+158
+30% +$38.7K 0.04% 145
2022
Q1
$129K Buy
532
+1
+0.2% +$230 0.03% 148
2021
Q4
$120K Buy
+531
New +$112K 0.03% 141
2020
Q2
Sell
-1,108
Closed -$225K 82
2020
Q1
$225K Sell
1,108
-112
-9% -$24.5K 0.12% 93
2019
Q4
$294K Hold
1,220
0.13% 119
2019
Q3
$236K Hold
1,220
0.12% 119
2019
Q2
$225K Buy
+1,220
New +$218K 0.12% 126

Other funds holding AMGN

Surevest's AMGN Position: Q3 2022 in Review

Surevest reduced its Amgen (AMGN) stake by 22% in Q3 2022, selling an estimated $37.6K and leaving 535 shares worth $121K. The position accounts for 0.03% of the portfolio, ranked #154.

Surevest first reported a position in AMGN in Q2 2019 and has held it in 8 quarters since. The position peaked at $294K in Q4 2019. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Surevest held 535 shares of Amgen worth $121K as of Q3 2022.
  • Surevest sold 155 Amgen shares in Q3 2022, an estimated $37.6K.
  • Amgen made up 0.03% of Surevest's portfolio in Q3 2022, its #154 holding.
  • Surevest first reported a position in Amgen in Q2 2019 and has held it in 8 quarters since.
  • Surevest's Amgen position peaked at $294K in Q4 2019.
  • 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.